Cargando…
Bone Morphogenetic Protein 10—A Novel Biomarker to Predict Adverse Outcomes in Patients With Atrial Fibrillation
BACKGROUND: Patients with atrial fibrillation (AF) face an increased risk of death and major adverse cardiovascular events (MACE). We aimed to assess the predictive value of the novel atrial‐specific biomarker BMP10 (bone morphogenetic protein 10) for death and MACE in patients with AF in comparison...
Autores principales: | Hennings, Elisa, Blum, Steffen, Aeschbacher, Stefanie, Coslovsky, Michael, Knecht, Sven, Eken, Ceylan, Lischer, Mirko, Paladini, Rebecca E., Krisai, Philipp, Reichlin, Tobias, Rodondi, Nicolas, Beer, Jürg H., Ammann, Peter, Conte, Giulio, De Perna, Maria Luisa, Kobza, Richard, Blum, Manuel R., Bossard, Matthias, Kastner, Peter, Ziegler, André, Müller, Christian, Bonati, Leo H., Pfister, Otmar, Zuern, Christine S., Conen, David, Kühne, Michael, Osswald, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10111531/ https://www.ncbi.nlm.nih.gov/pubmed/36926939 http://dx.doi.org/10.1161/JAHA.122.028255 |
Ejemplares similares
-
Association of bone morphogenetic protein 10 and recurrent atrial fibrillation after catheter ablation
por: Hennings, Elisa, et al.
Publicado: (2023) -
Bone morphogenetic protein 10 as a predictor for recurrent atrial fibrillation after catheter ablation
por: Hennings, E, et al.
Publicado: (2023) -
Association of pulmonary vein isolation and major cardiovascular events in patients with atrial fibrillation
por: Girod, Marc, et al.
Publicado: (2022) -
Biomarkers, Clinical Variables, and the CHA(2)DS(2)-VASc Score to Detect Silent Brain Infarcts in Atrial Fibrillation Patients
por: Krisai, Philipp, et al.
Publicado: (2021) -
Cardiac autonomic function and cognitive performance in patients with atrial fibrillation
por: Hämmerle, Peter, et al.
Publicado: (2021)